Foamix Pharmaceuticals appoints Dr Aaron Schwartz to its Board of Directors

– USA, NJ / ISRAEL, Rehovot – Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it has appointed Dr.…

Aerie Pharmaceuticals adds Richard Croarkin to the Board of Directors

– USA, CA, NJ, NC – Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that Richard Croarkin has been elected to the Company’s Board of Directors, effective May 7, 2015.…

Catalent adds Greg Lucier to the Board of Directors

– USA, NJ – Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has added Gregory T.…